{"name":"Jiangsu Simcere Biologics Co., Ltd","slug":"jiangsu-simcere-biologics-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPREpHNzU5VVVHcDBHTmVtbUFfalM5NmNEM0ZBUFFfTkhNTzNLVmxtdFhSUDZNRWJYUy0xdzhrUGVTZmU1NENvZnVDalI2RHItVENrZUd0VGFXYUhVenZxalRhQzVVTHdGYmxuV1I3VnRiYnU4bVMzSDRNZ05IbTZQTzJKdEc3WlhaeVA2OUxZWlBVRnVsZFB6dGduczNXaWlTbTliZU1iT3JCMTh6QURj?oc=5","date":"2026-01-05","type":"pipeline","source":"BioWorld News","summary":"Jiangsu Simcere Pharmaceutical describes new antibody-drug conjugates - BioWorld News","headline":"Jiangsu Simcere Pharmaceutical describes new antibody-drug conjugates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQdEFnQktFM210eXdiZmRhVlE4Y3FUTndfak5Cell5OFgyR1Z1QWxsaks4TzU0NTBvZlJIc0o3enpwWTlTYXBFR3o4eFZNZUg2QUpEZGN5Z3ZsTFRqTmZOMVBSZVpoa1YxT3ZHbFlaVVJOZHBWZjFkSE1jSFpXSVVpYVl2U1VhSHRJS1daVHZkSHAtLW5nbW1aeWZIZk9CQUxLNnVlYVF6VVZNRVdtT3ZpVzhMVkI1ODFPLUpqLWpBU3dEVnpWSldBX1JaTmZaX1VTUFJEc0hubWtXZGVwWmw4UmlyLUpTbk5MYVhCRENwaVByRVhzZXhobF9wUGJNYzUtMGNzWEFqbkN3enFKdFplVjJnYzVPQVduMDAzZ1Jn?oc=5","date":"2025-12-08","type":"regulatory","source":"GlobeNewswire","summary":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma - GlobeNewswire","headline":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPRVd6WXpfckdJZGoxTUJaOGRyaXpqcXgzX1RSS0xmRFp6MEx5NUJqQkZfaW5rQTRSMDBJWG9mZ2ZnQUMtZl9WTkhoNFdiZ1hyekYxUXczTzhhZlZtd1ZsSWg0d2plTnZPU3pUY0xsR0g0MnQ2OGUtcXdzOExuaEhJdDNoMGRLZ0owUzZ0WHFweHZRZnlrODBud0htTzUwcndEb1A2QzdQb3dOTFBMSGM3MmJCZEVmZmthNmdibmN6MnBNYmtFLTdNSzl3X2FZSmUyN3lNemFaQ1JmNnI2dU9ZLWVMSFgyQXlzU0thSGl3ZWpDbklKbjlpelA4WEFhQTlxMzIyYlB3cHRGNWhDRnVmb0Z0NlVOSnFSU3B0Zzh0eFgtbWlGTEtlMURhNjFUd3dFMEow?oc=5","date":"2025-07-21","type":"pipeline","source":"GlobeNewswire","summary":"Cutaneous T-cell Lymphoma Market Anticipates Impressive - GlobeNewswire","headline":"Cutaneous T-cell Lymphoma Market Anticipates Impressive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQRzl6R0F6T2dkNFJQdFZUN2ZIUFZVVEFkemRVSmhIcDZlbFA0TXZMTjlQQ0ROUnNDRGVfOTRTdXlYYXFRdUlWa01sX1JJaFJtT09QRE5HcjhMU0FfS2lkYTVneTVINWNIZWVOZ2ZNd3ptMzl1d2Z4ampfZ21WME5KQ0lYemhXQ0R5eXVQR3l1NVlsVXBET0pEcnRpV0g?oc=5","date":"2025-01-14","type":"trial","source":"Oncology Pipeline","summary":"AbbVie takes a tentative step into bispecific T-cell engagers | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"AbbVie takes a tentative step into bispecific T-cell engagers | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQZ3VIbDZCelllUXMzMUxFdWdkNzV2RzREVGdRR0t5SjRuQnFudW9aSEhVanlLSldoeDcxeXphSTFmRWl5VWF0V1pwVldfQ3cwRFpESmNuVUhvWVZWWUVXWXg1V3BMUndPT3NYR2ZQY0ttVktXYUw1UHlYVGsxZVRYZnJvTVZJMDNNeE5TZ1c4dUY4RWhfSFRZelNfMU0wRmt5dVQ2Tw?oc=5","date":"2024-12-10","type":"pipeline","source":"BioWorld News","summary":"NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye - BioWorld News","headline":"NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOV0hTc2FoTDQ1ZVRJTWtNVGU0ZHU4RGRCMFN5RFJ3MjB3VGtrdVJzenlfYU5aU0lyZ2NmRF9MbXlZTlppZGpFWURFaGZqZ2lKNkZUMERURUREajZDZFg1U0lydVg4cTJIa0lKZThHZFFCMk00WjllVVdJT2ZnNkZUaWphZHFzZzdneHc?oc=5","date":"2024-07-02","type":"regulatory","source":"BioWorld News","summary":"China approves first cetuximab biosimilar - BioWorld News","headline":"China approves first cetuximab biosimilar","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}